Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Appointed CFO Quarterly results CC transcript
|
PALISADE BIO, INC. (CUR)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
02/14/2023 |
SC 13G
| ARMISTICE CAPITAL, LLC reports a 10% stake in PALISADE BIO, INC. |
08/22/2022 |
SC 13G
| INTRACOASTAL CAPITAL, LLC reports a 10% stake in Palisade Bio, Inc. |
08/18/2022 |
SC 13G
| Lind Global Fund II LP reports a 6.2% stake in Palisade Bio, Inc. |
02/14/2022 |
SC 13G
| Altium Capital Management LP reports a 10% stake in Palisade Bio, Inc. |
05/10/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
05/29/2020 |
SC 13G
| ARMISTICE CAPITAL, LLC reports a 5% stake in Seneca Biopharma, Inc. |
02/12/2020 |
SC 13G
| RENAISSANCE TECHNOLOGIES LLC reports a 6.7% stake in SENECA BIOPHARMA, INC. |
08/09/2019 |
SC 13G
| INTRACOASTAL CAPITAL, LLC reports a 10% stake in Neuralstem, Inc. |
11/05/2018 |
SC 13G
| ARMISTICE CAPITAL, LLC reports a 5.7% stake in Neuralstem, Inc. |
10/26/2018 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
02/02/2018 |
SC 13G
| Hudson Bay Capital Management LP reports a 5.8% stake in Neuralstem, Inc. |
08/07/2017 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
08/22/2012 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
02/16/2012 |
SC 13G
| RUNNELS G TYLER reports a 6% stake in Neuralstem, Inc. |
|
|